Tag: BioPharma

GE’s BioPharma Deal Is at Risk

GE’s BioPharma Deal Is at Risk

We 100% disagree with Barron's that General Electric's deal to sell its BioPharma business to Danaher (tkr: DHR), for $21.4 billion (original deal announced February 2019), should close soon. This is precisely the type of large deal struck at a peak market that will either get delayed indefinitely or negotiated down. Danaher has the upper … Continue reading GE’s BioPharma Deal Is at Risk

Advertisements